Taro Provides Results for December 31, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Taro Pharma (TARO) Reports Q3 EPS of $1.37
February 7, 2018 5:28 PM ESTTaro Pharma (NYSE: TARO) reported Q3 EPS of $1.37, versus $3.42 reported last year. Revenue for the quarter came in at $155.5 million, versus $220.4 million reported last year.
Net income attributable to Taro was $18.0 million compared to $139.8 million, resulting in diluted earnings per share of $0.45... More
